Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer

Sorafenib, a tyrosine kinase inhibitor, has an important antitumor effect as a ferroptosis inducer in multiple cancers, including gastric cancer (GC). However, the status of sorafenib as a ferroptosis inducer has recently been questioned. There is very limited information about the relationship betw...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Xin, Li, Yaxian, Wu, Youliang, Wang, Mingliang, Lu, Yida, Fang, Ziqing, Wang, Huizhen, Li, Yongxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723522/
https://www.ncbi.nlm.nih.gov/pubmed/36473315
http://dx.doi.org/10.1016/j.redox.2022.102564

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723522/
https://www.ncbi.nlm.nih.gov/pubmed/36473315
http://dx.doi.org/10.1016/j.redox.2022.102564

Ejemplares similares